• Nano-Code: 2020-1-BG01-KA226-HE-095017
Partnership Area
What are you looking for?

Nanotechnology in detection, diagnosis and treatment of SARS-CoV-2

Which of the below is not a method for COVID-19 diagnosis.

One of the challenges of nanotechnology is its potential toxicity.

Nanobiosensors are devices in which the….is altered to catch the target component

Nanopore target sequencing simultaneously detects nine other respiratory viruses.

Conservative management of symptomatic COVID-19 is based on:

Paxlovid is:

May a fully vaccinated person contract and infection with SARS-CoV-2?

Monoclonal antibodies cannot be used for post-exposure prophylaxis of COVID-19.

Nanobiosensors offer accuracy and rapidity in diagnosing COVID-19.

Optical nanobiosensors are low sensitive.

Leave a Reply